Trials / Completed
CompletedNCT00095004
Study to Test an Approved Product in the Early Treatment of Migraine (0462-066)
A Multicenter, Double-Blind, Randomized, Parallel, Placebo-Controlled Study to Examine the Efficacy of Rizatriptan 10 mg Tablet Administered Early During a Migraine Attack While the Pain is Mild
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 167 (actual)
- Sponsor
- Organon and Co · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to test the effectiveness of an approved drug in the early treatment of migraine.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MK0462, rizatriptan benzoate / Duration of Treatment: 1day | |
| DRUG | Comparator: placebo / Duration of Treatment: 1 day |
Timeline
- Start date
- 2004-10-21
- Primary completion
- 2005-04-01
- Completion
- 2005-04-04
- First posted
- 2004-11-01
- Last updated
- 2024-08-14
Source: ClinicalTrials.gov record NCT00095004. Inclusion in this directory is not an endorsement.